Cargando…
Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014533/ https://www.ncbi.nlm.nih.gov/pubmed/29802143 http://dx.doi.org/10.2337/dc18-er07 |
| _version_ | 1783334254657142784 |
|---|---|
| author | Steinberg, William M. Rosenstock, Julio Wadden, Thomas A. Donsmark, Morten Jensen, Christine B. DeVries, J. Hans |
| author_facet | Steinberg, William M. Rosenstock, Julio Wadden, Thomas A. Donsmark, Morten Jensen, Christine B. DeVries, J. Hans |
| author_sort | Steinberg, William M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6014533 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60145332018-07-04 Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 Steinberg, William M. Rosenstock, Julio Wadden, Thomas A. Donsmark, Morten Jensen, Christine B. DeVries, J. Hans Diabetes Care Erratum American Diabetes Association 2018-07 2018-05-25 /pmc/articles/PMC6014533/ /pubmed/29802143 http://dx.doi.org/10.2337/dc18-er07 Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
| spellingShingle | Erratum Steinberg, William M. Rosenstock, Julio Wadden, Thomas A. Donsmark, Morten Jensen, Christine B. DeVries, J. Hans Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title | Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title_full | Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title_fullStr | Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title_full_unstemmed | Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title_short | Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 |
| title_sort | erratum. impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes, or type 2 diabetes: secondary analyses of pooled data from the scale clinical development program. diabetes care 2017;40:839–848 |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014533/ https://www.ncbi.nlm.nih.gov/pubmed/29802143 http://dx.doi.org/10.2337/dc18-er07 |
| work_keys_str_mv | AT steinbergwilliamm erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 AT rosenstockjulio erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 AT waddenthomasa erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 AT donsmarkmorten erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 AT jensenchristineb erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 AT devriesjhans erratumimpactofliraglutideonamylaselipaseandacutepancreatitisinparticipantswithoverweightobesityandnormoglycemiaprediabetesortype2diabetessecondaryanalysesofpooleddatafromthescaleclinicaldevelopmentprogramdiabetescare201740839848 |